Literature DB >> 128426

Mixed lymphocyte culture stimulatory and responding capacity of lymphocytes from patients with lymphoproliferative diseases.

H Rühl, W Vogt, G Bochert, S Schmidt, R Moelle, H Schaoua.   

Abstract

Lymphocyte reactivity in vitro was studied in patients with Hodgkin's disease, chronic lymphocytic leukaemia and lymphosarcoma. The responding capacity to phytohaemagglutinin (PHA) was markedly depressed and delayed in all three groups of patients compared with the PHA response observed in lymphocyte cultures from normal individuals. In one-way mixed lymphocyte culture experiments a significant decrease in responding capacity of the patients' lymphocytes to lymphocytes from normal donors could be demonstrated. In contrast, the stimulatory capacity of the patients' lymphocytes was found to be intact, or only slightly reduced.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 128426      PMCID: PMC1538031     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Studies on delayed hypersensitivity in Hodgkin's disease.

Authors:  A C AISENBERG
Journal:  J Clin Invest       Date:  1962-11       Impact factor: 14.808

Review 2.  HODGKIN'S DISEASE--PROGNOSIS, TREATMENT AND ETIOLOGIC AND IMMUNOLOGIC CONSIDERATIONS.

Authors:  A C AISENBERG
Journal:  N Engl J Med       Date:  1964-03-05       Impact factor: 91.245

3.  IMMUNOLOGIC AND CYTOGENETIC STUDIES OF CHRONIC LYMPHOCYTIC LEUKEMIC CELLS.

Authors:  J J OPPENHEIM; J WHANG; E FREI
Journal:  Blood       Date:  1965-08       Impact factor: 22.113

4.  A comparative study of the incidence of anergy in patients with carcinoma, leukemia, hodgkin's disease and other lymphomas.

Authors:  D LAMB; F PILNEY; W D KELLY; R A GOOD
Journal:  J Immunol       Date:  1962-10       Impact factor: 5.422

5.  Effects of phytohemagglutinin on rat and normal and leukemic human blood cells.

Authors:  R SCHREK; Y RABINOWITZ
Journal:  Proc Soc Exp Biol Med       Date:  1963-05

6.  Homologous and heterologous skin transplantation in patients with lymphomatous disease.

Authors:  D G MILLER; J G LIZARDO; R K SNYDERMAN
Journal:  J Natl Cancer Inst       Date:  1961-03       Impact factor: 13.506

7.  An investigation of Hodgkin's disease with respect to the problem of homotransplantation.

Authors:  W D KELLY; D L LAMB; R L VARCO; R A GOOD
Journal:  Ann N Y Acad Sci       Date:  1960-05-31       Impact factor: 5.691

8.  Differentiation of human leukemic leukocytes in tissue culture.

Authors:  P C NOWELL
Journal:  Exp Cell Res       Date:  1960-03       Impact factor: 3.905

9.  Impaired in vitro lymphocyte transformation in Hodgkin's disease.

Authors:  E M Hersh; J J Oppenheim
Journal:  N Engl J Med       Date:  1965-11-04       Impact factor: 91.245

10.  Human peripheral blood in tissue culture and the action of phytohemagglutinin.

Authors:  J H Robbins
Journal:  Experientia       Date:  1964-03-15
View more
  5 in total

1.  Poor mixed lymphocyte reaction stimulatory capacity of leukemic B cells of chronic lymphocytic leukemia patients despite the presence of Ia antigens.

Authors:  J P Halper; S M Fu; A B Gottlieb; R J Winchester; H G Kunkel
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

2.  Stimulation of human lymphocytes in vitro by leucocytes from patients with untreated acute myeloid leukaemia.

Authors:  G M Taylor; S V Jones; J C Ridway; R Harris
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

3.  Immunological capacity of lymphocytes from untreated patients with Hodgkin's disease evaluated in mixed lymphocyte culture.

Authors:  M Björkholm; G Holm; H Mellstedt; D Pettersson
Journal:  Clin Exp Immunol       Date:  1975-12       Impact factor: 4.330

4.  Human mixed lymphocyte culture using separated lymphocyte populations.

Authors:  M R Potter; M Moore
Journal:  Immunology       Date:  1977-03       Impact factor: 7.397

5.  Stimulation by CLL cells in mixed lymphocyte culture (MLC).

Authors:  E H Jones; A B Hockley; S D Lawler
Journal:  Br J Cancer       Date:  1981-11       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.